Technical Analysis for BPTH - Bio-Path Holdings Inc
| ADX | Long-Term | Intermediate-Term | Short-Term |
|---|---|---|---|
| Very Strong | Up | Up | Up |
| See historical BPTH trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Mar 18 | Calm After Storm | Range Contraction | 0.00% |
| Mar 18 | Narrow Range Bar | Range Contraction | 0.00% |
| Mar 18 | NR7 | Range Contraction | 0.00% |
| Mar 18 | Wide Bands | Range Expansion | 0.00% |
| Mar 15 | Calm After Storm | Range Contraction | -5.48% |
| Mar 15 | Earnings Movers | Other | -5.48% |
| Mar 15 | Multiple of Ten Bearish | Other | -5.48% |
| Mar 15 | Wide Bands | Range Expansion | -5.48% |
| Mar 14 | Calm After Storm | Range Contraction | 1.16% |
| Mar 14 | NR7 | Range Contraction | 1.16% |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 2019-03-14
- Sector: Healthcare
- Industry: Biotechnology & Medical Research
Bio-Path Holdings, Inc., a biotechnology company, focuses on developing therapeutic products utilizing its proprietary liposomal delivery technology to systemically distribute nucleic acid drugs throughout the human body with a simple intravenous transfusion. Its lead product candidate, Liposomal Grb-2, is in a Phase I study for blood cancers and in preclinical studies for triple negative and inflammatory breast cancers. The company's other drug candidate, Liposomal Bcl-2, is ready for the clinic where it would be evaluated in lymphoma and solid tumors. Bio-Path Holdings, Inc. was founded in 2007 and is based in Houston, Texas.
Biotechnology Solid Tumors Breast Cancer Cell Biology Lymphoma Therapeutic Products Oncogenes Apoptosis Blood Cancers
Biotechnology Solid Tumors Breast Cancer Cell Biology Lymphoma Therapeutic Products Oncogenes Apoptosis Blood Cancers
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength | |||
| Summary: | Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies. | ||
See more BPTH news...
Indicators
| Indicator | Value |
|---|---|
| 52 Week High | 73.52 |
| 52 Week Low | 1.61 |
| Average Volume | 4,622,577 |
| 200-Day Moving Average | 16.7193 |
| 50-Day Moving Average | 7.3611 |
| 20-Day Moving Average | 14.4935 |
| 10-Day Moving Average | 25.89 |
| Average True Range | 6.7231 |
| ADX | 71.64 |
| +DI | 50.6834 |
| -DI | 5.0167 |
| Chandelier Exit (Long, 3 ATRs ) | 53.3507 |
| Chandelier Exit (Short, 3 ATRs ) | 22.0093 |
| Upper Bollinger Band | 41.3691 |
| Lower Bollinger Band | -12.3821 |
| Percent B (%b) | 0.75 |
| BandWidth | 370.86418 |
| MACD Line | 7.398 |
| MACD Signal Line | 5.7344 |
| MACD Histogram | 1.6636 |
| Fundamentals | Value |
|---|---|
| Market Cap | 2.78 Billion |
| Num Shares | 100 Million |
| EPS | -0.07 |
| Price-to-Earnings (P/E) Ratio | -397.00 |
| Price-to-Sales | 3232.58 |
| Price-to-Book | 4.77 |
| PEG Ratio | 0.00 |
| Dividend | 0.00 |
| Dividend Yield | 0.00% |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 32.05 | ||||
| Resistance 3 (R3) | 32.26 | 31.05 | 31.34 | ||
| Resistance 2 (R2) | 31.05 | 29.97 | 30.95 | 31.10 | |
| Resistance 1 (R1) | 29.42 | 29.29 | 28.82 | 29.21 | 30.87 |
| Pivot Point | 28.21 | 28.21 | 27.91 | 28.11 | 28.21 |
| Support 1 (S1) | 26.58 | 27.13 | 25.98 | 26.37 | 24.71 |
| Support 2 (S2) | 25.37 | 26.45 | 25.27 | 24.48 | |
| Support 3 (S3) | 23.74 | 25.37 | 24.24 | ||
| Support 4 (S4) | 23.53 |
